GO:0106419 NAD-dependent protein lipoamidase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0106419 describes NAD-dependent protein lipoamidase activity, an enzymatic reaction that removes a lipoyl group from a lipoylated lysine residue on a protein while consuming NAD+.
• The reaction converts (R)-N6-lipoyl-L-lysyl-[protein] plus H2O and NAD+ into 2''-O-lipoyl-ADP-D-ribose, L-lysyl-[protein], and nicotinamide.
• Sirtuin family enzymes, especially mitochondrial SIRT4, are the best-characterized proteins linked to this activity in mammalian cells.
• This activity connects mitochondrial metabolism, protein post-translational modification, and cellular stress responses, making it relevant to cancer and neurodegenerative disease research.
• Studying GO:0106419 requires combining genetic models, biochemical assays, and proteomic or metabolomic readouts to distinguish direct catalysis from downstream effects.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models are powerful tools for testing whether a candidate enzyme causally mediates NAD-dependent protein lipoamidase activity.
Description
NAD-dependent protein lipoamidase activity, indexed as GO:0106419, is a molecular function that removes a lipoyl modification from a protein lysine residue in a reaction that consumes NAD+. This activity sits at the intersection of mitochondrial metabolism and post-translational modification because lipoylation is a conserved modification of key metabolic enzyme complexes, and its removal can change enzyme function. Researchers study this activity to understand how cells remodel mitochondrial proteins under metabolic stress and how such remodeling contributes to disease. The best-characterized mammalian enzyme associated with this activity is SIRT4, a mitochondrial sirtuin that has been reported to act as a lipoamidase and to influence metabolism, cancer biology, and mitochondrial quality control. Because the reaction uses NAD+ and produces nicotinamide and a lipoyl-ADP-ribose product, it links protein deacylation chemistry to cellular redox and energy status. This article summarizes the definition, mechanism, key genes, disease relevance, and experimental strategies for studying GO:0106419, with all factual claims supported by the verified literature.
NAD-dependent protein lipoamidase activity At A Glance
| GO ID | GO:0106419 |
|---|---|
| GO term | NAD-dependent protein lipoamidase activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Removes a lipoyl group from a lipoylated lysine residue on a protein using NAD+ and water |
| Reaction | (R)-N6-lipoyl-L-lysyl-[protein] + H2O + NAD+ = 2''-O-lipoyl-ADP-D-ribose + L-lysyl-[protein] + nicotinamide |
| Representative enzyme | SIRT4 is the best-characterized mammalian protein linked to this activity |
| Cellular context | Mitochondrial metabolism and protein post-translational modification |
| Disease relevance | Cancer metabolism and neurodegenerative disease research |
What Is GO:0106419?
GO:0106419, NAD-dependent protein lipoamidase activity, is defined as catalysis of the reaction: (R)-N6-lipoyl-L-lysyl-[protein] + H2O + NAD+ = 2''-O-lipoyl-ADP-D-ribose + L-lysyl-[protein] + nicotinamide. In simpler terms, the enzyme takes a protein that carries a lipoyl group on a lysine side chain, uses NAD+ and water, and releases the unmodified lysine plus two reaction products. This is a hydrolytic, NAD-dependent deacylation reaction rather than a simple protease or phosphatase event. The activity is classified as a molecular_function in the Gene Ontology and is most closely associated with sirtuin-type enzymes in the literature.
Why Is NAD-dependent protein lipoamidase activity Important in Cell Biology?
NAD-dependent protein lipoamidase activity matters because it directly couples NAD+ availability to the removal of a metabolic modification on mitochondrial proteins, thereby linking energy status to protein function. Because lipoylation controls the activity of key metabolic enzyme complexes, an enzyme that removes lipoyl groups can act as a metabolic switch under stress or nutrient limitation. SIRT4, the main enzyme associated with this activity, has been implicated in the regulation of mitochondrial metabolism, cancer cell proliferation, and mitochondrial quality control in neurodegenerative disease models. Understanding GO:0106419 therefore helps researchers interpret how mitochondrial protein modifications are dynamically regulated and how their dysregulation may contribute to disease.
• It provides a direct biochemical link between NAD+ metabolism and protein lipoylation status.
• It is a molecular mechanism by which mitochondrial enzymes can be functionally remodeled.
• SIRT4, the best-characterized enzyme for this activity, influences cancer cell metabolism and tumor biology.
• Altered sirtuin activity, including SIRT4, has been connected to mitochondrial quality control in neurodegenerative disease.
• The reaction produces nicotinamide, connecting this activity to cellular NAD+ salvage and redox balance.
• It offers a potential target for metabolic and oncology research aimed at mitochondrial pathways.
• It helps explain how post-translational modifications beyond phosphorylation and acetylation shape metabolism.
• It supports the development of assays and genetic models to test causal roles of candidate lipoamidases.
Molecular Mechanism of NAD-dependent protein lipoamidase activity
Substrate recognition and lipoyl-lysine binding
In simple terms: The enzyme first finds and binds a protein that carries a lipoyl tag on a lysine residue.
The reaction begins with recognition of a substrate protein bearing an (R)-N6-lipoyl-L-lysyl modification. This lipoyl group is a bulky, hydrophobic acyl modification typically found on conserved lysine residues of metabolic enzyme complexes. The enzyme must position this lipoyl-lysine in its active site so that the lipoyl group can be attacked and removed. Because the substrate is a modified protein rather than a small molecule, substrate recognition depends on both the lipoyl moiety and the surrounding protein surface.
NAD+ binding and cofactor role
In simple terms: NAD+ is the cofactor that powers the removal reaction.
NAD+ binds in the enzyme active site and participates directly in the chemistry of lipoyl removal. The reaction consumes NAD+ and produces nicotinamide, which is a hallmark of NAD-dependent deacylation reactions. This requirement means the activity is sensitive to cellular NAD+ levels and to pathways that regulate NAD+ biosynthesis and salvage. The NAD+ dependence also distinguishes this activity from simple hydrolases that do not require a dinucleotide cofactor.
Catalysis and product formation
In simple terms: The enzyme cuts the bond between the lipoyl group and lysine, releasing several products.
Catalysis converts (R)-N6-lipoyl-L-lysyl-[protein] plus H2O and NAD+ into 2''-O-lipoyl-ADP-D-ribose, L-lysyl-[protein], and nicotinamide. The protein product is the unmodified lysine form, meaning the substrate protein loses its lipoyl modification. The generation of 2''-O-lipoyl-ADP-D-ribose is a distinctive feature of this reaction and can be used analytically to monitor enzyme activity. Because the reaction is hydrolytic and NAD-dependent, it is mechanistically related to other sirtuin-catalyzed deacylation reactions.
Regulation by NAD+ availability and metabolic state
In simple terms: How much NAD+ is available and how the cell is metabolizing fuel can change how active this enzyme is.
Because NAD+ is a required co-substrate, the activity of NAD-dependent protein lipoamidase is expected to track with cellular NAD+ availability and metabolic state. SIRT4, the best-characterized enzyme linked to this activity, is a mitochondrial sirtuin whose functions are intertwined with mitochondrial metabolism and stress responses. Changes in nutrient availability, mitochondrial function, or NAD+ salvage can therefore influence the effective rate of lipoyl removal. This regulatory logic places GO:0106419 within the broader network of sirtuin-mediated metabolic control.
Downstream consequences for mitochondrial proteins
In simple terms: Removing the lipoyl tag can change how target proteins work inside mitochondria.
Loss of a lipoyl modification can alter the activity or assembly of mitochondrial enzyme complexes that depend on lipoylation. By removing lipoyl groups, NAD-dependent protein lipoamidase activity can act as a switch that tunes mitochondrial metabolism. SIRT4 has been reported to influence mitochondrial metabolism and quality control, consistent with a role for this activity in mitochondrial homeostasis. These downstream effects are central to why the activity is studied in cancer and neurodegenerative disease contexts.
Key Genes Involved in GO:0106419 NAD-dependent protein lipoamidase activity
The following genes and proteins are the most relevant to NAD-dependent protein lipoamidase activity based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SIRT4 | Mitochondrial sirtuin reported to act as a lipoamidase and metabolic regulator | Central enzyme for studying GO:0106419 in cancer and metabolism |
| SIRT1 | NAD-dependent deacetylase in the sirtuin family | Comparator for NAD-dependent deacylation mechanisms |
| SIRT2 | NAD-dependent deacetylase with roles in cellular stress responses | Context for sirtuin family diversity in deacylation |
| SIRT3 | Mitochondrial sirtuin involved in mitochondrial quality control | Comparison for mitochondrial sirtuin functions |
| SIRT5 | Mitochondrial sirtuin with distinct acyl-lysine preferences | Contrast for substrate specificity within the family |
| SIRT6 | Nuclear sirtuin linked to genome stability and metabolism | Broader sirtuin biology context |
| SIRT7 | Nuclear sirtuin involved in stress and ribosomal regulation | Family-level comparison for NAD-dependent enzymes |
| NAMPT | Enzyme in the NAD+ salvage pathway | Modulates NAD+ supply for NAD-dependent activities |
| NMNAT | Enzyme that synthesizes NAD+ intermediates | Relevant to cofactor availability for GO:0106419 |
| DLAT | Lipoylated metabolic enzyme component | Potential substrate context for lipoyl removal |
| DLD | Lipoylated dehydrogenase complex component | Potential substrate context for lipoyl removal |
| PDHA1 | Pyruvate dehydrogenase component with lipoyl-dependent function | Metabolic pathway context for lipoylation |
| LIAS | Lipoyl synthase required for protein lipoylation | Upstream control of substrate availability |
| LIPT1 | Lipoyl transferase involved in protein lipoylation | Upstream control of substrate availability |
| MTOR | Central metabolic regulator influencing mitochondrial function | Signaling context for metabolic regulation |
| AMPK | Energy sensor that coordinates mitochondrial metabolism | Stress context for NAD-dependent regulation |
| PPARGC1A | Transcriptional coactivator of mitochondrial biogenesis | Mitochondrial remodeling context |
| TP53 | Tumor suppressor linked to metabolic stress responses | Cancer context for mitochondrial sirtuin biology |
How Is NAD-dependent protein lipoamidase activity Regulated?
NAD-dependent protein lipoamidase activity is regulated at least in part by the availability of its NAD+ co-substrate, which is controlled by NAD+ biosynthesis and salvage pathways. Because SIRT4 is the best-characterized enzyme for this activity, its expression and mitochondrial localization also influence the effective level of lipoyl removal. Mitochondrial metabolic state, nutrient availability, and stress signaling can change NAD+ levels and thereby modulate this activity. In addition, sirtuins are subject to multiple layers of regulation, including protein-protein interactions and post-translational modifications, which can affect their catalytic output. Together, these layers make GO:0106419 responsive to the broader metabolic and stress state of the cell.
NAD-dependent protein lipoamidase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SIRT4 | Cancer metabolism and tumor biology | SIRT4 knockout and overexpression cancer cell lines |
| SIRT4 | Mitochondrial quality control in neurodegeneration | Neuronal cell models with SIRT4 modulation |
| NAMPT | NAD+ salvage and metabolic stress | NAMPT perturbation with NAD+ measurement |
| DLAT | Lipoylation-dependent mitochondrial metabolism | Lipoylation site mutation models |
| LIAS | Protein lipoylation pathway | LIAS knockout to reduce substrate lipoylation |
Cancer metabolism and tumor biology
SIRT4, the enzyme most closely associated with NAD-dependent protein lipoamidase activity, has been studied as a multifaceted enzyme at the crossroads of mitochondrial metabolism and cancer. Its functions in cellular metabolism and its reported roles in human cancer make it a candidate for understanding how mitochondrial protein modification influences tumor growth. Because the activity consumes NAD+ and removes lipoyl groups from metabolic enzymes, it may contribute to the metabolic reprogramming observed in cancer cells. Experimental work in cancer models has therefore focused on how changes in SIRT4 levels or activity affect proliferation and metabolic pathways.
Neurodegenerative disease and mitochondrial quality control
Sirtuins sit at the crossroads between mitochondrial quality control and neurodegenerative diseases, and SIRT4 is part of this broader family. Mitochondrial dysfunction is a recurring theme in neurodegeneration, and enzymes that modify mitochondrial proteins can influence neuronal survival. NAD-dependent protein lipoamidase activity may therefore be relevant to how neurons handle metabolic stress and mitochondrial damage. Research in this area uses sirtuin-focused models to test whether modulating this activity changes disease-relevant phenotypes.
Mitochondrial metabolism and metabolic stress
The reaction catalyzed by GO:0106419 directly connects NAD+ status to protein lipoylation, a modification central to mitochondrial energy metabolism. When NAD+ levels or mitochondrial function change, the balance of lipoylation and delipoylation can shift, potentially altering metabolic flux. This makes the activity relevant to conditions characterized by metabolic stress, including nutrient limitation and mitochondrial dysfunction. Studying this activity can therefore illuminate how cells adapt their mitochondrial proteome to changing metabolic demands.
From NAD-dependent protein lipoamidase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of the candidate enzyme change lipoyl removal? | CRISPR knockout cell line |
| Is a specific catalytic residue required for activity? | Point-mutation knock-in of the catalytic residue |
| Does tagging the enzyme affect localization or interactions? | Tagged knock-in of the endogenous locus |
| Does increased enzyme dosage alter metabolism? | Overexpression cell model |
| Which proteins lose lipoylation upon enzyme activation? | Proteomic analysis in knockout versus wild-type cells |
| Does the activity affect mitochondrial function? | Seahorse or mitochondrial respiration assays in edited cells |
How to Study the NAD-dependent protein lipoamidase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NAD+ consumption assay | Enzymatic consumption of NAD+ | Confirming NAD-dependent lipoamidase activity |
| Product detection for 2''-O-lipoyl-ADP-D-ribose | Formation of the ADP-ribose product | Validating the specific reaction chemistry |
| Lipoylation proteomics | Changes in protein lipoylation | Identifying substrate proteins and pathways |
| Mitochondrial respiration assay | Mitochondrial metabolic function | Linking activity to cellular metabolism |
| Western blot for candidate enzymes | Protein expression and modification state | Validating knockout or overexpression models |
| Immunofluorescence imaging | Subcellular localization | Confirming mitochondrial localization |
| CRISPR knockout screening | Gene requirement for a phenotype | Discovering regulators of the activity |
| Transcriptomics after perturbation | Gene expression changes | Mapping downstream transcriptional responses |
Biochemical activity assays
Direct measurement of NAD-dependent protein lipoamidase activity requires assays that detect the consumption of NAD+ or the formation of reaction products such as 2''-O-lipoyl-ADP-D-ribose and nicotinamide. These assays can be performed with recombinant enzyme and defined lipoylated substrates to establish catalytic activity. Coupling activity assays with NAD+ quantification helps confirm that the reaction is NAD-dependent. Such biochemical approaches are essential for distinguishing direct catalysis from downstream cellular effects.
Proteomics and lipoylation profiling
Because the reaction removes lipoyl groups from proteins, proteomic methods that enrich or detect lipoylated peptides can reveal substrate candidates and global changes in lipoylation. Comparing wild-type and enzyme-deficient cells can identify proteins whose lipoylation status depends on the activity. These analyses help map the downstream consequences of GO:0106419 in mitochondrial metabolism. Combining proteomics with genetic perturbation strengthens causal inference.
Metabolic and mitochondrial function assays
Since lipoylation is central to mitochondrial energy metabolism, metabolic assays such as respiration measurements and metabolite profiling are used to assess the functional impact of the activity. Changes in mitochondrial function can be compared between cells with and without the candidate enzyme. These readouts connect the molecular function to cellular physiology. They are particularly useful in cancer and neurodegeneration models where mitochondrial metabolism is relevant.
Genetic and CRISPR-based perturbation
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to test the causal role of a candidate enzyme in NAD-dependent protein lipoamidase activity. Knockout removes the enzyme entirely, while point mutations can test specific catalytic residues. Tagged knock-in enables localization and interaction studies at endogenous expression levels. Overexpression can reveal gain-of-function effects on metabolism and disease phenotypes.
How CRISPR Can Be Used to Study GO:0106419 NAD-dependent protein lipoamidase activity
Knockout
CRISPR knockout of a candidate enzyme such as SIRT4 removes the protein and allows researchers to test whether NAD-dependent protein lipoamidase activity and its downstream metabolic effects are lost. Knockout cell lines can be compared with wild-type cells in activity assays, lipoylation proteomics, and metabolic measurements. This approach is foundational for establishing causality between the enzyme and the molecular function. Knockout models are also useful for identifying compensatory pathways that may mask the phenotype.
Point Mutation
Point-mutation knock-in can be used to mutate catalytic residues of the candidate enzyme while preserving its expression and localization. This strategy distinguishes the catalytic activity of GO:0106419 from other scaffolding or interaction functions of the protein. Comparing wild-type and catalytic-dead mutants in activity assays provides strong evidence for direct enzymatic function. Point mutants are also valuable for testing whether a specific residue is required for substrate recognition or NAD+ binding.
Knock-in
Tagged knock-in of the endogenous locus allows the candidate enzyme to be studied at physiological expression levels with a detectable tag. This is useful for localization studies, interaction proteomics, and monitoring protein stability. Knock-in models avoid the artifacts that can arise from strong overexpression. They are particularly helpful when the enzyme is mitochondrial and its localization is functionally important.
Overexpression
Overexpression of a candidate enzyme such as SIRT4 can reveal gain-of-function effects on lipoylation, metabolism, and disease-relevant phenotypes. Overexpression models are useful for testing whether increased activity is sufficient to change mitochondrial function or cell proliferation. They can also be combined with activity assays to confirm that the overexpressed protein is catalytically active. However, results from overexpression should be interpreted alongside knockout and knock-in data to avoid artifacts.
How EDITGENE Supports NAD-dependent protein lipoamidase activity Research
Researchers studying NAD-dependent protein lipoamidase activity-related genes often need to determine whether a candidate gene is causally involved in the reaction, how its catalytic residues work, and what downstream metabolic or disease phenotypes depend on its activity. Answering these questions requires well-controlled genetic models that can isolate the enzyme's catalytic function from its other roles. EDITGENE provides a suite of CRISPR-based services designed to support exactly this kind of mechanistic and translational research.
Contact EDITGENE today to design your custom CRISPR model for NAD-dependent protein lipoamidase activity research.
Frequently Asked Questions About NAD-dependent protein lipoamidase activity
What is NAD-dependent protein lipoamidase activity?
It is a molecular function, GO:0106419, that removes a lipoyl group from a lipoylated lysine residue on a protein using NAD+ and water, producing an unmodified protein, 2''-O-lipoyl-ADP-D-ribose, and nicotinamide.
What is the reaction catalyzed by GO:0106419?
The reaction is (R)-N6-lipoyl-L-lysyl-[protein] + H2O + NAD+ = 2''-O-lipoyl-ADP-D-ribose + L-lysyl-[protein] + nicotinamide.
Which enzyme is most associated with NAD-dependent protein lipoamidase activity?
SIRT4, a mitochondrial sirtuin, is the best-characterized mammalian enzyme linked to this activity in the literature.
What genes are involved in NAD-dependent protein lipoamidase activity?
SIRT4 is the central gene, and broader sirtuin family members such as SIRT1, SIRT2, SIRT3, SIRT5, SIRT6, and SIRT7 provide context for NAD-dependent deacylation biology.
Why is NAD+ important for this activity?
NAD+ is a required co-substrate that is consumed during the reaction, so the activity depends on cellular NAD+ availability and NAD+ salvage pathways.
How is NAD-dependent protein lipoamidase activity linked to cancer?
SIRT4 has been studied as a multifaceted enzyme at the crossroads of mitochondrial metabolism and cancer, and its functions in cellular metabolism and human cancer are active research areas.
Is this activity relevant to neurodegenerative disease?
Sirtuins sit at the crossroads between mitochondrial quality control and neurodegenerative diseases, making this activity relevant to mitochondrial dysfunction in neurons.
How can researchers study GO:0106419?
Researchers use biochemical activity assays, lipoylation proteomics, metabolic measurements, and CRISPR-based genetic models to study this activity.
What CRISPR models are useful for studying this activity?
Knockout, point-mutation, knock-in, tagged knock-in, and overexpression models are all useful for testing the causal role of candidate enzymes.
What products are formed by this reaction?
The products are 2''-O-lipoyl-ADP-D-ribose, L-lysyl-[protein], and nicotinamide.
Conclusion
NAD-dependent protein lipoamidase activity, GO:0106419, is a NAD+-consuming molecular function that removes lipoyl groups from proteins and thereby connects mitochondrial metabolism to post-translational modification. SIRT4 is the best-characterized enzyme associated with this activity, and its roles in cancer metabolism and mitochondrial quality control make the activity relevant to both oncology and neurodegeneration research. Studying GO:0106419 requires a combination of biochemical assays, proteomic profiling, metabolic readouts, and well-controlled CRISPR genetic models. With these tools, researchers can determine how lipoyl removal shapes mitochondrial function and whether targeting this activity has therapeutic potential.
References
- 1. Tomaselli D et al.. 2020. Sirt4: A Multifaceted Enzyme at the Crossroads of Mitochondrial Metabolism and Cancer.. Front Oncol 10:474 PMID: 32373514
- 2. Wang C et al.. 2020. Functions of mammalian SIRT4 in cellular metabolism and research progress in human cancer.. Oncol Lett 20(4):11 PMID: 32774484
- 3. Xu H et al.. 2023. Sirtuins at the Crossroads between Mitochondrial Quality Control and Neurodegenerative Diseases: Structure, Regulation, Modifications, and Modulators.. Aging Dis 14(3):794-824 PMID: 37191431
